Yoshii Y, Saito A, Nose T
Dept. of Neurological Surgery, University of Tsukuba, Ibaraki, Japan.
J Neurooncol. 1995 Oct;26(1):1-9. doi: 10.1007/BF01054763.
In 48 patients with gliomas in whom complete clinical follow-up was obtained, DNA ploidy was evaluated by using formalin-fixed paraffin-embedded tissues and by means of image analysis. The mean DNA indices, determined by averaging DNA indices of all tumor cells in a tumor, were mainly affected by mean DNA indices of the nuclei of SG2M phase tumor cell (including S phase and G2M phase cells) (SG2M DNA indices) and that mean DNA indices correlated with the SG2M phase fraction. The SG2M DNA indices and the percentage of tumor cells with S phase and G2M phase were higher in high grade gliomas including anaplastic glioma and glioblastoma multiforme than in low grade gliomas. Patients with G2M-hypertetraploid tumors demonstrated a shorter time to tumor progression than those with G2M-tetraploid in high grade glioma. Morphometrically, the nuclei of SG2M phase glioma cells were larger and more deformity than those of G0G1 phase (including G0 phase and G1 phase cells) cells. The G2M-hypertetraploid tumors were highly malignant and demonstrated large nuclei, greater nuclear deformity, and a higher proliferative potential. The G2M-tetraploid gliomas demonstrated a shorter time to tumor progression in cases whose the SG2M fraction was large. In contrast, G2M-hypotetraploid gliomas revealed an insignificant trend towards a longer time to tumor progression than those associated with tetraploid and hypertetraploid gliomas. We emphasize herein the prognostic importance of the SG2M phase cell, as well as other proliferation indices.
在48例获得完整临床随访的胶质瘤患者中,采用福尔马林固定石蜡包埋组织并通过图像分析评估DNA倍体。通过对肿瘤中所有肿瘤细胞的DNA指数进行平均确定的平均DNA指数,主要受SG2M期肿瘤细胞核(包括S期和G2M期细胞)的平均DNA指数(SG2M DNA指数)影响,且该平均DNA指数与SG2M期分数相关。包括间变性胶质瘤和多形性胶质母细胞瘤在内的高级别胶质瘤的SG2M DNA指数以及S期和G2M期肿瘤细胞的百分比高于低级别胶质瘤。在高级别胶质瘤中,G2M - 超四倍体肿瘤患者的肿瘤进展时间比G2M - 四倍体患者短。形态计量学上,SG2M期胶质瘤细胞核比G0G1期(包括G0期和G1期细胞)细胞核更大且更畸形。G2M - 超四倍体肿瘤具有高度恶性,表现为细胞核大、核畸形更明显以及增殖潜能更高。在SG2M分数大的病例中,G2M - 四倍体胶质瘤的肿瘤进展时间较短。相比之下,G2M - 亚四倍体胶质瘤的肿瘤进展时间比四倍体和超四倍体胶质瘤患者有延长的趋势,但差异不显著。我们在此强调SG2M期细胞以及其他增殖指数的预后重要性。